147 related articles for article (PubMed ID: 1913615)
21. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
Maeura Y; Weisburger JH; Williams GM
Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
[TBL] [Abstract][Full Text] [Related]
22. Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat.
Kitano M; Ichihara T; Matsuda T; Wanibuchi H; Tamano S; Hagiwara A; Imaoka S; Funae Y; Shirai T; Fukushima S
Carcinogenesis; 1998 Aug; 19(8):1475-80. PubMed ID: 9744545
[TBL] [Abstract][Full Text] [Related]
23. Chemopreventive effects of scordinin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.
Watanabe T; Sugie S; Okamoto K; Rahman KM; Ushida J; Mori H
Jpn J Cancer Res; 2001 Jun; 92(6):603-9. PubMed ID: 11429047
[TBL] [Abstract][Full Text] [Related]
24. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
Williams GM; Furuya K
Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
[TBL] [Abstract][Full Text] [Related]
25. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
LeBoeuf RA; Laishes BA; Hoekstra WG
Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
[TBL] [Abstract][Full Text] [Related]
26. Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats.
Kim DJ; Lee KK; Han BS; Ahn B; Bae JH; Jang JJ
Jpn J Cancer Res; 1994 Jun; 85(6):578-83. PubMed ID: 8063610
[TBL] [Abstract][Full Text] [Related]
27. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.
Lee GH; Ooasa T; Osanai M
Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of dietary iron deficiency on the induction of putative preneoplastic foci in rat liver initiated with diethylnitrosamine and promoted by phenobarbital.
Yoshiji H; Nakae D; Kinugasa T; Matsuzaki M; Denda A; Tsujii T; Konishi Y
Br J Cancer; 1991 Nov; 64(5):839-42. PubMed ID: 1681886
[TBL] [Abstract][Full Text] [Related]
30. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay.
Shibutani M; Takahashi N; Kobayashi T; Uneyama C; Masutomi N; Nishikawa A; Hirose M
Carcinogenesis; 2002 Jun; 23(6):1047-55. PubMed ID: 12082028
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-nitrosodiethylamine in juvenile B6C3F1 mice.
Diwan BA; Rice JM; Ward JM; Ohshima M; Lynch PH
Cancer Lett; 1984 Jun; 23(2):223-34. PubMed ID: 6744246
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
[TBL] [Abstract][Full Text] [Related]
33. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Lee YS; Nishikawa A
J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
[TBL] [Abstract][Full Text] [Related]
34. Different responses to phenobarbital promotion in the development of gamma-glutamyltranspeptidase-positive foci in the liver of rats initiated with diethylnitrosamine, N-hydroxy-2-acetyl-aminofluorene and aflatoxin B1.
Shirai T; Imaida K; Ohshima M; Fukushima S; Lee MS; King CM; Ito N
Jpn J Cancer Res; 1985 Jan; 76(1):16-9. PubMed ID: 2857671
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of butylated hydroxytoluene-associated modification of diethylnitrosamine-induced squamous stomach carcinoma.
Daugherty JP
Food Chem Toxicol; 1984 Dec; 22(12):951-61. PubMed ID: 6542546
[TBL] [Abstract][Full Text] [Related]
36. Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.
Shirai T; Hosoda K; Hirose K; Hirose M; Ito N
Cancer Lett; 1985 Sep; 28(2):127-33. PubMed ID: 2865001
[TBL] [Abstract][Full Text] [Related]
37. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration.
Goldsworthy T; Campbell HA; Pitot HC
Carcinogenesis; 1984 Jan; 5(1):67-71. PubMed ID: 6140089
[TBL] [Abstract][Full Text] [Related]
38. A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model.
Sun H; Yu L; Wei H; Liu G
J Biomed Biotechnol; 2012; 2012():584728. PubMed ID: 22500097
[TBL] [Abstract][Full Text] [Related]
39. Dose-related inhibition of aflatoxin B1 induced hepatocarcinogenesis by the phenolic antioxidants, butylated hydroxyanisole and butylated hydroxytoluene.
Williams GM; Tanaka T; Maeura Y
Carcinogenesis; 1986 Jul; 7(7):1043-50. PubMed ID: 2872975
[TBL] [Abstract][Full Text] [Related]
40. Promotion potential of tamoxifen on hepatocarcinogenesis in female SD or F344 rats initiated with diethylnitrosamine.
Kim DJ; Han BS; Ahn B; Lee KK; Kang JS; Tsuda H
Cancer Lett; 1996 Jun; 104(1):13-9. PubMed ID: 8640739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
